A Trial of Hetrombopag in Healthy Subjects

Clinical trial NCT05088174 · COMPLETED

Trial details

NCT number: NCT05088174
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sever Aplastic Anaemia

Start date: 2020-09-03
Primary completion: 2020-10-22
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.